Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.7200
+0.0189
+(2.70%)
As of 9:48:24 AM EST. Market Open.
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 17.33M | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
Beraldo, Albert George Director of Issuer | Acquisition or disposition in the public market at price 0.88 per share. | Direct | 28,632 | Feb 13, 2025 |
Beraldo, Albert George Director of Issuer | Acquisition or disposition in the public market at price 0.90 per share. | Direct | 11,635 | Feb 13, 2025 |
Beraldo, Albert George Director of Issuer | Acquisition or disposition in the public market at price 0.90 per share. | Direct | 2,525 | Feb 13, 2025 |
Beraldo, Albert George Director of Issuer | Acquisition or disposition in the public market at price 0.91 per share. | Direct | 454 | Feb 13, 2025 |
Hyman (David) Senior Officer of Issuer | Acquisition or disposition in the public market at price 1.01 per share. | Direct | 20,140 | Jan 9, 2025 |
Beraldo, Albert George Director of Issuer | -- | Direct | -- | Dec 2, 2024 |
Dawes (Karen A) Director of Issuer | -- | Direct | -- | Nov 29, 2024 |
Merchant (Fahar) 10% Security Holder of Issuer | Exercise of options at price 0.28 per share. | Direct | 114,781 | Jun 3, 2024 |
Merchant (Rosemina) 10% Security Holder of Issuer | Exercise of options at price 0.28 per share. | Direct | 96,670 | Jun 3, 2024 |
Related Tickers
EPRX Eupraxia Pharmaceuticals Inc.
3.9500
-2.47%
NGENF NervGen Pharma Corp.
1.9100
+0.53%
PDSB PDS Biotechnology Corporation
1.3300
-2.21%
CRGX CARGO Therapeutics, Inc.
3.6475
+0.21%
DAWN Day One Biopharmaceuticals, Inc.
9.13
-3.23%
MREO Mereo BioPharma Group plc
2.4050
-1.84%
MSCL.TO Satellos Bioscience Inc.
0.8200
+2.50%
INZY Inozyme Pharma, Inc.
1.1700
-2.50%
ACXP Acurx Pharmaceuticals, Inc.
0.6963
+1.50%
RP.V RepliCel Life Sciences Inc.
0.0100
0.00%